Stay updated on Nab-sirolimus in Brain Cancer Clinical Trial
Sign up to get notified when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.

Latest updates to the Nab-sirolimus in Brain Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Added Revision: v3.3.2 and removed Revision: v3.2.0 in the page's version history. This is a minor administrative update with no observable changes to trial details or navigation.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the notice about lapse in government funding and the NIH/OPM operating status from the page. The page now presents only the study details.SummaryDifference0.4%

- Check33 days agoChange DetectedResults have been posted on the study record (Results First Posted 2023-11-07), with updates to the study results section reflecting the trial outcomes.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a prominent operating-status notice and updated the version to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference3%

- Check69 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.SummaryDifference0.1%

- Check83 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Nab-sirolimus in Brain Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-sirolimus in Brain Cancer Clinical Trial page.